Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: The Realities of Tuberculosis Treatment for the Patients
7:40 pm - 7:45 pm
Introduction by Discussion Leader
7:45 pm - 8:05 pm
Late-Breaking Topic
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:40 pm
"Paediatric Tuberculosis Disease Pathogenesis Offers Unique Therapeutic Opportunities"
8:40 pm - 8:50 pm
Discussion
8:50 pm - 9:20 pm
"Establishing Community Peer-Led Monitoring Systems for TB Projects-Lessons Learned from Ubumi Bwandi Project in an Urban Community in Zambia"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Tools and Models for Drug Development, Discovery, and Analysis of Resistance
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Granulomas and Tuberculosis Therapy"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Disrupting Cord Architectures as Host-Directed Therapy in Mycobacterium Tuberculosis Infections"
10:05 am - 10:15 am
Discussion
10:15 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Advanced In Vitro Tools to Inform Progression of Novel TB Drug Regimens"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"AI-Enabled Anti-TB Hit ID and LO"
11:40 am - 11:50 am
Discussion
11:50 am - 12:15 pm
"Phage Therapy for Tuberculosis - Tough Challenges and Unique Opportunities"
12:15 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hour™
The GRC Power Hour™ is designed to address the interests and needs of all scientists and the challenges they face in their careers. Specifically, the program promotes meaningful conversations amongst colleagues of all career stages about barriers to career advancement and strategies to support the professional growth of all members of the community. The GRC Power Hour™ is open to all conference participants.
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Approaches to Seeking New Chemical Matter
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"New Strategies for Tuberculosis Therapy"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"Logical Luck: Mixing Methods for Modern Small Molecule Discovery"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"DDU384, the Journey from Phenotypic Hit Towards Preclinical Selection"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Improving TB Chemotherapy, Including Through Translational Science and Clinical Trial Design
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Lesion-Centric PK and PD Considerations for TB Drug Discovery and Regimen Design"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Personalized CD8 T-Cell Immunity: Computational Approaches to Profile Patient-Specific Responses Against Tuberculosis"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Early Bactericidal Activity, Safety and PK of the New Alpibectir-Ethionamide Combination (AlpE) for the Treatment of TB"
11:10 am - 11:20 am
Discussion
11:20 am - 11:30 am
Short Talk Selected from Poster Abstracts
11:30 am - 11:35 am
Discussion
11:35 am - 11:45 am
Short Talk Selected from Poster Abstracts
11:45 am - 11:50 am
Discussion
11:50 am - 12:00 pm
Short Talk Selected from Poster Abstracts
12:00 pm - 12:05 pm
Discussion
12:05 pm - 12:15 pm
Short Talk Selected from Poster Abstracts
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Partnering Diagnostic Approaches with the Development and Implementation of Therapeutic Strategies
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Implementing New Therapeutic Strategies for Tuberculosis"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"From New Insights into Pathogenesis to Host-Directed Diagnosis and Treatment for TB Meningitis in Clinical Cohorts"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"How to Improve the Alignment Between New Drugs and Diagnostics for the Treatment of Tuberculosis"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Finding and Optimizing Lead Compounds and Strategies to Treat Tuberculosis
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"New Therapeutic Approaches for Tuberculosis"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Recent Efforts in the Translation of Mycobacterium Tuberculosis KasA Inhibitors"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Development of a Novel Liposomal Oxazolidinone as a Long Acting Injectable for the Treatment of Multidrug-Resistant Tuberculosis"
11:10 am - 11:20 am
Discussion
11:20 am - 11:30 am
Short Talk Selected from Poster Abstracts
11:30 am - 11:35 am
Discussion
11:35 am - 11:45 am
Short Talk Selected from Poster Abstracts
11:45 am - 11:50 am
Discussion
11:50 am - 12:00 pm
Short Talk Selected from Poster Abstracts
12:00 pm - 12:05 pm
Discussion
12:05 pm - 12:15 pm
Short Talk Selected from Poster Abstracts
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Structural, Computational, and Chemical Genetic Approaches to Identify Ways to Treat Tuberculosis
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Targeting the Terminal Respiratory Oxidases: Pretomanid, Telacebec, and Emerging Synergistic Strategies for Tuberculosis"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"Targeting Transcription in Mycobacterium Tuberculosis: A Strategic Approach to Develop Synergistic Treatments"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:25 pm
Short Talk Selected from Poster Abstracts
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
Short Talk Selected from Poster Abstracts
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Leveraging the Host to Fight Tuberculosis
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Bioenergetic Crosstalk Between Host and Pathogen Mediates Drug Tolerance in Mycobacterium Tuberculosis "
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Host-Directed Therapy to Enhance Treatment Shortening"
10:05 am - 10:15 am
Discussion
10:15 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Targeting Lipid Droplets to Achieve Host Mediated Control of TB Infection"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"Randomly Barcoded Transposon Sequencing Reveals Novel Determinants of M. Tuberculosis Strategies for Nutrient Acquisition and Resistance to Stress"
11:40 am - 11:50 am
Discussion
11:50 am - 12:15 pm
"CRISPR/Cas9 Editing of Primary Human Macrophages to Define Targets for Host-Directed Therapy for TB"
12:15 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Advancing our Understanding of Mycobacterium Tuberculosis to Improve Tuberculosis Chemotherapy
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Probing Mycobacterial Cell Envelope Perturbations"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"Differentially Culturable Bacteria in Tuberculosis Treatment, Relapse, and Transmission: Challenging a Century of Dogma"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure